Analysed TAYSHA GENE THERAPIES INC (TSHA:NASDAQ) News Sources
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05-06-2026
yahoo.com
Taysha Gene Therapies (TSHA) Stock Looks Undervalued After Sharp Three Year Recovery
13-06-2026
yahoo.com
Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome
22-06-2026
yahoo.com
Taysha Advances Rett Syndrome Programme as Pivotal Trial Enrollment Completes (TSHA)
22-06-2026
advfn.com
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
24-06-2026
yahoo.com
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
25-06-2026
yahoo.com
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
25-06-2026
yahoo.com
What is the current price of TAYSHA GENE THERAPIES INC (TSHA:NASDAQ)?
The current price of TAYSHA GENE THERAPIES INC (TSHA:NASDAQ) is $6.34.
TAYSHA GENE THERAPIES INC (TSHA:NASDAQ) absolute price change since previous trading day?
The absolute price change of TAYSHA GENE THERAPIES INC (TSHA:NASDAQ) since the previous trading day is $-0.23.
TAYSHA GENE THERAPIES INC (TSHA:NASDAQ) percentage price change since previous trading day?
The percentage price change of TAYSHA GENE THERAPIES INC (TSHA:NASDAQ) since the previous trading day is -3.5008%.
What is the most recent average sentiment score for TAYSHA GENE THERAPIES INC (TSHA:NASDAQ)?
The most recent average sentiment score for TAYSHA GENE THERAPIES INC (TSHA:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for TAYSHA GENE THERAPIES INC (TSHA:NASDAQ)?
The most recent sentiment for TAYSHA GENE THERAPIES INC (TSHA:NASDAQ) is .
SEC-8K** Filing Available For TAYSHA GENE THERAPIES INC (TSHA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.